Unal, E. Et Al. 2021. Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study. Biochemical Genetics , vol.59, no.6 , 1413-1426.

Unal, E., Aslan, E. I., ÖZTÜRK, T., Kurnaz Gomleksiz, O., KÜÇÜKHÜSEYİN, Ö., Tuzuner, M. B., ... SEYHAN, M. F.(2021). Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study. Biochemical Genetics , vol.59, no.6, 1413-1426.

Unal, Esra Et Al. "Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study," Biochemical Genetics , vol.59, no.6, 1413-1426, 2021

Unal, Esra Et Al. "Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study." Biochemical Genetics , vol.59, no.6, pp.1413-1426, 2021

Unal, E. Et Al. (2021) . "Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study." Biochemical Genetics , vol.59, no.6, pp.1413-1426.

@article{article, author={Esra Unal Et Al. }, title={Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study}, journal={Biochemical Genetics}, year=2021, pages={1413-1426} }